Author:
de Lourdes Setsuko Ayrizono Maria,de Sene Portel Oliveira Priscilla,José Fagundes João
Reference32 articles.
1. Ponzo MG, Hong CH. A dermatologist’s guide to infection screening prior to initiating immunosuppressive therapy. Skin Therapy Letter. 2017;22(1):8-11
2. Available at: https://www.cdc.gov/mmwr/previent/mmwrhtml/rr5515a1htm
3. Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V, et al. ECCO-ESGAR guideline for assessment in IBD part 1: Initial diagnosis, monitoring of know IBD, detection of complications. Journal of Crohn’s and Colitis. 2019;13(2):144-64K
4. Rahier JF, Magro F, Abreu C, Armuzz A, Ben-Horis S, Chowees Y, et al. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. Journal of Crohn’s and Colitis. 2014;8(6):443-468
5. Nordgaard-Lanssen I, Dahlerup JF, Belard E, Gerstof J, Kjeldsen J, Kragballe K, et al. Guidelines for information prior to initiating anti-TNF-alpha treatment. Danish Medical Journal. 2012;59(7):C4480